Elara Capital predicts positive impacts on Indian IT, pharma, EMS, and defence sectors under Trump's policies.
In India, foreign investors have sold more than $1.5 billion of ... currencies because of their export orientation and sensitivity to a potential slowdown in China’s growth. The ringgit, Southeast ...
This initiative has borne fruit with a growing presence by Apple and other tech giants seeking to diversify their supply chains out of China. And India's biggest tech companies, including TCS and ...
The HQ-19 anti-ballistic missile defense system is expected to offer China a robust shield against ballistic missile threats.
Donald Trump has vowed to impose blanket tariffs of up to 20 per cent on imports from all countries, as well as tariffs on Chinese imports in excess of 60 per cent.
IT and pharma may gain from Trump's second term, India must capitalise on chance to deepen defence ties with US, Jindal Steel and Power record decent quarter, should investors subscribe for this ...
Five years ago, Prime Minister Modi made a bold, risky call that has now materialized—ushering in Modi-Trump 2.0. These two leaders, who share a rare and visible friendship, have now set the stage for ...
Donald Trump's re-election as US President has sparked global concern, particularly in Canada. Trump's 'America First' agenda, with potential trade ta ...
Dr Aghi said that as India forms trade partnerships with the UAE, Australia, is in discussion with the UK and the EU, the confidence in both the domestic market as well as in the political leadership ...
In 2019, India decided to not join the bloc, on the grounds that the deal would hurt its farmers, businesses, workers and consumers ...
China must be stopped and Bhutan must be supported in order to undo this dangerous precedent where one huge and powerful country is bullying a small one to maximise its power and ambition ...
Asian equities, excluding China, witnessed sharp foreign outflows in October, as investors wary of the U.S. presidential election outcome reacted to concerns over weaker-than-expected corporate ...